NCT02313194View on ClinicalTrials.gov

Spinal Cord Neuromodulation for Spinal Cord Injury

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2026

Conditions
Cervical Spinal Cord InjuryTetraparesisTetraplegia
Interventions
DEVICE

Epidural Stimulation

Determine if epidural stimulation can improve motor function

DRUG

Buspirone

Determine if the pharmacological agent in combination with the stimulator can improve motor function.

Trial Locations (1)

90095

UCLA, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT02313194 - Spinal Cord Neuromodulation for Spinal Cord Injury | Biotech Hunter | Biotech Hunter